MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.heliyon.2024.e29447

Медицинская библиотека · Heliyon · 2024

Anticancer potential of grifolin in lung cancer treatment through PI3K/AKT pathway inhibition.

Wang Li, Wang Yongjun, Wang Zexu, Zhang Xiuwei, Chen Huayong, Lin Qiuqi, Wang Xin, Wen Yuting, Pan Xia, Guo Zhongliang, Wan Bing

СтатьяПеревод в очереди

Аннотация

OBJECTIVE

Grifolin is a natural secondary metabolite isolated from edible fruiting bodies of the mushroom Albatrellus confluens. Grifolin has antitumor activities in several types of cancer. We aimed to determine the effects of grifolin on lung cancer.

METHODS

We determined the proliferation, migration, invasion, and apoptosis of lung cancer cells using 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, Ethynyl deoxyuridine, colony formation, wound scratch, transwell, flow cytometry, and xenograft mouse assays. Molecular docking evaluated the binding relation between grifolin and phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA). The levels of PIK3CA, AKT, and p-AKT were measured by western blot.

RESULTS

Grifolin (10, 20, or 40 μM) inhibited the proliferation, migration, and invasion of lung cancer cells, and induced cell cycle arrest and apoptosis. Grifolin also decreased CDK4, CDK6, and CyclinD1 expression and significantly decreased PIK3CA and p-AKT expression in lung cancer cells. These anticancer effects were abolished by 740Y-P.

CONCLUSIONS

Grifolin regulates the PI3K/AKT pathway, thus inhibiting lung cancer progression.

Для цитирования: Wang Li, Wang Yongjun, Wang Zexu, Zhang Xiuwei, Chen Huayong, Lin Qiuqi, Wang Xin, Wen Yuting, Pan Xia, Guo Zhongliang, Wan Bing. Anticancer potential of grifolin in lung cancer treatment through PI3K/AKT pathway inhibition.. Heliyon. 2024. DOI: 10.1016/j.heliyon.2024.e29447.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.